Literature DB >> 3406668

An epidemic outbreak of group B meningococcal disease on the Faroe Islands.

P Weihe1, B Mathiassen, J M Rasmussen, T Petersen, H Isager.   

Abstract

An epidemic of group B meningococcal disease on the Faroe Islands is described. A peak annual incidence of 95 cases/100,000 was reached in 1981. The time at which the epidemic commenced cannot be determined due to inadequate diagnostic facilities, but was presumably around the end of the 1970s. The incidence fell to 29 cases/100,000 in 1985, which indicates that the Faroe Islands are still a high incidence area. A total of 203 cases of meningococcal disease were recorded during the period 1978-1985 with 11 deaths (lethality rate 5.4%). After rifampicin was introduced in 1981 as prophylactic treatment against secondary cases, 1,892 persons were treated with this agent and none of these appeared in the study population. Before rifampicin prophylaxis was introduced, the number of cases were distributed with an evenly increasing incidence in the capital and in the provinces. Following the introduction of rifampicin as prophylactic agent, a fall in the incidence in both areas was observed. This fall was more pronounced in the capital, where the number of prescribed prophylactic doses per case of meningococcal disease was higher than in the province.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3406668     DOI: 10.3109/00365548809032454

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  4 in total

1.  An outbreak of serogroup B:15:P1.16 meningococcal disease, Frederiksborg County, Denmark, 1987-9.

Authors:  S Samuelsson; P Ege; L Berthelsen; I Lind
Journal:  Epidemiol Infect       Date:  1992-02       Impact factor: 2.451

2.  Pharyngeal carriage of Neisseria meningitidis and Neisseria lactamica in households with infants within areas with high and low incidences of meningococcal disease.

Authors:  S F Olsen; B Djurhuus; K Rasmussen; H D Joensen; S O Larsen; H Zoffman; I Lind
Journal:  Epidemiol Infect       Date:  1991-06       Impact factor: 2.451

Review 3.  Complement deficiency states and meningococcal disease.

Authors:  J Figueroa; J Andreoni; P Densen
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

Review 4.  Current status of meningococcal group B vaccine candidates: capsular or noncapsular?

Authors:  J Diaz Romero; I M Outschoorn
Journal:  Clin Microbiol Rev       Date:  1994-10       Impact factor: 26.132

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.